• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4637602)   Today's Articles (443)   Subscriber (50124)
For: Effat KG, Madany NM. Mycological study on cholesteatoma keratin obtained during primary mastoid surgery. J Laryngol Otol 2014;128:881-4. [DOI: 10.1017/s0022215114002059] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]

Middle ear cholesteatoma (MEC) is a destructive and locally invasive ulcerated lesion in the middle ear driven by inflammation which occurs in 10 out of 100,000 people annually. Surgical extraction/excision is the only treatment strategy available and recurrence is high (up to 40% after ten years), therefore developing the first pharmaceutical treatments for MEC is desperately required. This review is focused on the connections between inflammation and MEC pathogenesis. These connections can be used as attack points for pharmaceuticals. For this we summarized the results of research undertaken over the last 30 + years. MEC pathogenesis can be described by specific inflammatory dysregulation already known from arthritis, Crohn’s disease or multiple sclerosis. A hallmark of this dysregulation are positive feedback loops of the inflammation further amplifying itself in a vicious circle-like manner. We have identified over one hundred drugs which are already used in clinic to treat other inflammatory diseases, and could potentially be repurposed to treat MEC. To improve and expedite clinical success rates, we applied certain criteria based on our literature searches and condensed these drugs down to the 13 top drugs. We hope the review will serve as groundwork for the primary goal, which is to provide potential pharmaceutical therapies to MEC patients for the first time in history.

Collapse
Number Cited by Other Article(s)
1
Schürmann M, Goon P, Sudhoff H. Review of potential medical treatments for middle ear cholesteatoma. Cell Commun Signal 2022;20:148. [PMID: 36123729 PMCID: PMC9487140 DOI: 10.1186/s12964-022-00953-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Accepted: 08/05/2022] [Indexed: 11/15/2022]  Open

Video Abstract

  • Matthias Schürmann
    • Department of Otolaryngology, Head and Neck Surgery, Universität Bielefeld, Teutoburger Str. 50, 33604, Bielefeld, Germany
  • Peter Goon
    • Department of Otolaryngology, Head and Neck Surgery, Universität Bielefeld, Teutoburger Str. 50, 33604, Bielefeld, Germany.,Department of Medicine, National University of Singapore, and National University Health System, Singapore, Singapore
  • Holger Sudhoff
    • Department of Otolaryngology, Head and Neck Surgery, Universität Bielefeld, Teutoburger Str. 50, 33604, Bielefeld, Germany.
Collapse
2
Singh GB, Nair M, Kaur R. Is there fungal infestation in paediatric chronic otitis media - Mucosal disease? Am J Otolaryngol 2022;43:103435. [PMID: 35398742 DOI: 10.1016/j.amjoto.2022.103435] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Accepted: 04/02/2022] [Indexed: 11/15/2022]
3
Jiang H, Wu C, Xu J, Wang Q, Shen L, Ou X, Liu H, Han X, Wang J, Ding W, Hu L, Chen X. Bacterial and Fungal Infections Promote the Bone Erosion Progression in Acquired Cholesteatoma Revealed by Metagenomic Next-Generation Sequencing. Front Microbiol 2021;12:761111. [PMID: 34803987 PMCID: PMC8604023 DOI: 10.3389/fmicb.2021.761111] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/19/2021] [Accepted: 10/11/2021] [Indexed: 01/08/2023]  Open
4
The Role of Biofilms in Chronic Otitis Media-Active Squamosal Disease: An Evaluative Study. Otol Neurotol 2021;42:e1279-e1285. [PMID: 34528922 DOI: 10.1097/mao.0000000000003259] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
5
Singh GB, Solo M, Kaur R. A Rare Case of Candida Mastoiditis in an Immunocompetent Patient With Cholesteatoma Ear Disease. EAR, NOSE & THROAT JOURNAL 2020;101:NP193-NP195. [PMID: 32921188 DOI: 10.1177/0145561320957757] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]  Open
6
Singh GB, Solo M, Kaur R, Arora R, Kumar S. Mycology of chronic suppurative otitis media-cholesteatoma disease: An evaluative study. Am J Otolaryngol 2018;39:157-161. [PMID: 29306568 DOI: 10.1016/j.amjoto.2017.12.001] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2017] [Accepted: 12/01/2017] [Indexed: 11/25/2022]
7
Likus W, Siemianowicz K, Markowski J, Wiaderkiewicz J, Kostrząb-Zdebel A, Jura-Szołtys E, Dziubdziela W, Wiaderkiewicz R, Łos MJ. Bacterial Infections and Osteoclastogenesis Regulators in Men and Women with Cholesteatoma. Arch Immunol Ther Exp (Warsz) 2015;64:241-7. [PMID: 26584851 DOI: 10.1007/s00005-015-0373-7] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/01/2015] [Accepted: 10/12/2015] [Indexed: 01/06/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA